Propylene glycol-induced side effects during intravenous nitroglycerin therapy. 1988

H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
Department of Intensive Care, University of Antwerp U.I.A., University Hospital, Edegem, Belgium.

Propylene glycol, an alcohol frequently used as a solvent in medical preparations, is considered non-toxic. We found that this solvent, used in a commercially available IV nitroglycerin solution, may cause hyperosmolality, hemolysis and lactic acidosis. The influence of kidney function as the main determinant in causing accumulation of this solvent and consequently hyperosmolality is emphasized. A review of the literature dealing with propylene glycol is given. The possible mechanisms of neurological disturbances occurring during IV nitroglycerin therapy are discussed.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011409 Propylene Glycols Derivatives of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations. Propanediols,Glycols, Propylene
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
July 1985, American heart journal,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
May 1987, Critical care medicine,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
June 1979, American journal of veterinary research,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
September 1987, Therapeutic drug monitoring,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
January 1985, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
November 1962, Toxicology and applied pharmacology,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
September 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
September 2000, The New England journal of medicine,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
March 1998, Annals of emergency medicine,
H E Demey, and R A Daelemans, and G A Verpooten, and M E De Broe, and C M Van Campenhout, and F V Lakiere, and P J Schepens, and L L Bossaert
March 1985, JAMA,
Copied contents to your clipboard!